GRABAR LAW OFFICE INVESTIGATES CLAIMS AGAINST OFFICERS AND DIRECTORS OF ADAPTHEALTH CORP. (NASDAQ: AHCO)
AdaptHealth Corp. is a home medical equipment supplier providing devices for diabetes, sleep apnea, and wound care. AdaptHealth sells medical devices directly to patients, and then bills patients’ insurance providers, including the Centers for Medicare and Medicaid Services (“CMS”).
A securities fraud class action has been filed on behalf of all persons or entities who purchased or otherwise acquired: (i) AdaptHealth (NASDAQ: AHCO) common stock during the Class Period; and/or (ii) AdaptHealth common stock pursuant and/or traceable to the Company’s secondary public offering conducted on or around January 5, 2021.
The Complaint alleges that AdaptHealth, via certain of its senior executives orchestrated a scheme to overcharge CMS and other insurance providers by submitting improper billing codes for diabetes equipment. The Complaint further alleges that to facilitate this scheme, AdaptHealth and certain of its senior executives made numerous false and misleading statements to investors during the Class Period, and that as a result of these misrepresentations, AdaptHealth common stock traded at artificially inflated prices.
On May 28, 2025, the parties in the class action informed the Court that “Lead Plaintiffs and Defendants have agreed to schedule a mediation.”
On June 24, the Court Ordered a stay in the case pending the outcome of mediation proceedings.
Current AdaptHealth shareholders who have held AdaptHealth shares since prior to either August 4, 2020, or prior to the Secondary Public Offering of January 5, 2021, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award at no cost to them whatsoever.
If you would like to learn more about this matter, you are encouraged to contact us at jgrabar@grabarlaw.com, or call 267-507-6085.